Chinese Journal of Tissue Engineering Research ›› 2021, Vol. 25 ›› Issue (15): 2358-2363.doi: 10.3969/j.issn.2095-4344.3803

Previous Articles     Next Articles

In vitro experiment of tetrandrine on the model of osteolysis induced by wear particles around the prosthesis

Liu Zige1, 2, Liu Xinrui2, Li Yan3, Song Guorui1, Zhang Chen1, Chen Desheng4    

  1. 1School of Clinical Medicine of Ningxia Medical University, Ningxia Hui Autonomous Region, China; 2Key Laboratory of Fertility Preservation and Maintenance, Key Laboratory of Reproduction and Genetics in Ningxia, Ningxia Hui Autonomous Region, China; 3Basic Medical School, Ningxia Medical University, Ningxia Hui Autonomous Region, China; 4Department of Orthopedics, General Hospital of Ningxia Medical University, Ningxia Hui Autonomous Region, China 
  • Received:2020-06-17 Revised:2020-06-20 Accepted:2020-07-20 Online:2021-05-28 Published:2021-01-05
  • Contact: Chen Desheng, MD, Chief physician, Professor, Department of Orthopedics, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China
  • About author:Liu Zige, Master candidate, Physician, School of Clinical Medicine of Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China; Key Laboratory of Fertility Preservation and Maintenance, Key Laboratory of Reproduction and Genetics in Ningxia, Yinchuan 750004, Ningxia Hui Autonomous Region, China
  • Supported by:
    the National Natural Science Foundation of China, No. 81560364,  81760405 (to CDS); the National Natural Science Foundation of China, No. 81760395 (to LY)

Abstract: BACKGROUND: There are few domestic studies on the formation and differentiation of osteoclasts induced by wear particles by tetrandrine.   
OBJECTIVE: To explore the positive effect of tetrandrine on the osteolysis model of mouse RAW264.7 macrophages induced by titanium particles under different concentrations. 
METHODS: Mouse RAW264.7 macrophages were divided into five groups for culture: blank group, experimental group (0.1 g/L titanium particle suspension), and low, medium, and high concentration drug groups (component+0.1, 0.5, and 1.0 μmol/L tetrandrine). CCK-8 assay was used to detect the proliferative activity of RAW264.7. The anti-tartaric acid phosphatase staining method and the phalloidin staining method were used to detect the function and number of mature osteoclasts. The enzyme-linked immunosorbent assay was used to detect the cell supernatant expression of tumor necrosis factor-α and matrix metalloproteinase-9. RT-PCR was applied to detect mRNA expression of activated T cell nuclear factor c1, tumor necrosis factor-α, and matrix metalloproteinase 9. Western blot assay was utilized to detect the levels of phosphorylated proteins of nuclear factor κB p65 and IκBα. 
RESULTS AND CONCLUSION: (1) Compared with the blank group, the various concentrations of tetrandrine had no effect on the proliferation of RAW264.7 cells (P > 0.05). (2) In the control group, more bigger, wine red, and F-actin ring stained with fluorescent green multinucleated osteoclasts were observed, and after treatment with different concentrations of tetrandrine, the number of osteoclast cells decreased significantly (P < 0.05); and the size of F-actin ring decreased with the increase of drug concentration. (3) Compared with the blank group, IκBα and nuclear factor κB p65 and their phosphorylation levels, tumor necrosis factor-α, matrix metalloproteinase-9 cell culture supernatant protein expression, activated T cell nuclear factor c1 mRNA, tumor necrosis factor-α mRNA, matrix metalloproteinase-9 mRNA expression levels were significantly increased in the experimental group (P < 0.05). Tetrandrine reduced the expression of the above indexes in a concentration-dependent manner. (4) In summary, tetrandrine can have a positive effect on the in vitro osteolysis model of mouse RAW264.7 macrophages induced by titanium particles by inhibiting the nuclear factor κB signaling pathway. 

Key words: tetrandrine, titanium particles, nuclear factor κB, aseptic loosening, osteolysis, artificial prosthesis 

CLC Number: